Valeant Stock Is Cheap Enough for Valuation Expert to Own: Chart

Valeant Pharmaceuticals International Inc.’s shares have become cheap enough to attract Aswath Damodaran, a finance professor at New York University and the author of four books on company valuation. Damodaran valued Valeant at $43.66 a share in a blog posting Wednesday. “It looked like a good investment at $32 late last week, and I own it now,” he wrote.

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE